Fri, August 7, 2015
Thu, August 6, 2015
Wed, August 5, 2015
Tue, August 4, 2015
Mon, August 3, 2015
Fri, July 31, 2015

Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $168 on, Aug 4th, 2015

Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $163 to $168 on, Aug 4th, 2015.

Christopher has made no other calls on BMRN in the last 4 months.



There are 5 other peers that have a rating on BMRN. Out of the 5 peers that are also analyzing BMRN, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Christopher


  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $156 on, Thursday, June 18th, 2015
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $151 on, Thursday, June 18th, 2015
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $156 on, Thursday, June 18th, 2015
  • Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $145 on, Thursday, June 18th, 2015
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Thursday, June 18th, 2015


Similar Stocks and Investing Publications